ENTITY
Beijing Airdoc Technology

Beijing Airdoc Technology (2251 HK)

41
Analysis
Information Technology • China
Beijing Airdoc Technology provides AI-empowered retina-based solutions for early detection, diagnosis, and health risk assessment of chronic diseases. The company offers AI-based software solutions, such as Airdoc-AIFUNDUS for retinal disease diagnosis, and hardware devices, leveraging retinal imaging and deep learning algorithms. It was founded in 2015 and is headquartered in Beijing, China.
more
•26 Sep 2021 11:33

ECM Weekly (26th September 2021) - Hanyu Med, Abbisko, SenseTime, ANE, Nykaa, Prudential HK

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Logo
653 Views
Share
•24 Sep 2021 01:35

Beijing Airdoc IPO: First Mover in Retina-Based Early Detection and Diagnosis

Airdoc has the first mover advantage for its core product with limited competition (one other product). Once AIFUNDUS 2.0&3.0 are approved, they...

Share
•09 Sep 2021 13:14

Beijing Airdoc (北京鹰瞳科技) Pre-IPO - A Niche Field with Merits but Can It Sell?

Beijing Airdoc is looking to raise up to US$500m in its Hong Kong IPO. It is an medical device company with a focus on AI-empowered retina-based...

Logo
420 Views
Share
•29 Jul 2021 09:23

Pre-IPO Beijing Airdoc Technology - The Strength and the Concerns

This article mainly analyzed Airdoc Technology in terms of both the strength and the concerns through the perspectives of the business, the...

Logo
462 Views
Share
x